Y. Chen, “The Impact of the R&D Investments towards Short-term Corporate Valuation -- Evidence from Chinese Listed Healthcare Companies”, BCPBM, vol. 31, pp. 257–265, Nov. 2022, doi: 10.54691/bcpbm.v31i.2590.